BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22098344)

  • 1. Innovations in the treatment of cystic fibrosis: outriders for the treatment of diseases with other genetic defects?
    Schubert-Zsilavecz M; Merk D
    Future Med Chem; 2011 Dec; 3(16):1969-70. PubMed ID: 22098344
    [No Abstract]   [Full Text] [Related]  

  • 2. [Problems posed by genetic diseases: cystic fibrosis].
    Bellon G; Reix P
    Rev Prat; 2006 Apr; 56(8):883-90. PubMed ID: 16764250
    [No Abstract]   [Full Text] [Related]  

  • 3. [Protein repair therapy in cystic fibrosis].
    Clément A; Tamalet A; Fauroux B; Epaud R
    Rev Prat; 2003 Jan; 53(2):163-6. PubMed ID: 12664848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular repair of a defective CFTR protein in cystic fibrosis.
    Erlinger S
    Clin Res Hepatol Gastroenterol; 2011 Apr; 35(4):254-6. PubMed ID: 21349786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cystic fibrosis and gene therapy].
    Setoguchi Y; Yokoyama T
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():607-16. PubMed ID: 16416861
    [No Abstract]   [Full Text] [Related]  

  • 6. [Modifier genes and cystic fibrosis].
    Corvol H; Flamant C; Vallet C; Clement A; Brouard J
    Arch Pediatr; 2006 Jan; 13(1):57-63. PubMed ID: 16274977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [From gene transfer to gene therapy in cystic fibrosis, how long is the road?].
    Bellon G
    Rev Prat; 1998 Jan; 48(1):5-8. PubMed ID: 9781203
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes].
    Schwartz M
    Ugeskr Laeger; 2003 Feb; 165(9):912-6. PubMed ID: 12661515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New therapeutic approaches in cystic fibrosis].
    Vestner A; Schrepfer B; Kockler J; Mohr F; Zündorf I; Dingermann T
    Pharm Unserer Zeit; 2008; 37(5):354-5. PubMed ID: 18729285
    [No Abstract]   [Full Text] [Related]  

  • 10. Fixing cystic fibrosis CFTR with correctors and potentiators. Off to a good start.
    Elborn JS
    Thorax; 2012 Jan; 67(1):4-5. PubMed ID: 22058188
    [No Abstract]   [Full Text] [Related]  

  • 11. Understanding cystic fibrosis, improving life expectancy.
    Bentley P
    Nurs Times; 1999 Oct 27-Nov 2; 95(43):50-1. PubMed ID: 10847084
    [No Abstract]   [Full Text] [Related]  

  • 12. Homozygosity for L997F in a child with normal clinical and chloride secretory phenotype provides evidence that this cystic fibrosis transmembrane conductance regulator mutation does not cause cystic fibrosis.
    Derichs N; Schuster A; Grund I; Ernsting A; Stolpe C; Körtge-Jung S; Gallati S; Stuhrmann M; Kozlowski P; Ballmann M
    Clin Genet; 2005 Jun; 67(6):529-31. PubMed ID: 15857421
    [No Abstract]   [Full Text] [Related]  

  • 13. Twenty years after cystic fibrosis gene identification: Where are we and what are we up to?
    Edelman A; Fritsch J; Ollero M
    Pathol Biol (Paris); 2011 Jun; 59(3):131-3. PubMed ID: 19896304
    [No Abstract]   [Full Text] [Related]  

  • 14. Gene therapy for cystic fibrosis.
    Davies JC; Geddes DM; Alton EW
    J Gene Med; 2001; 3(5):409-17. PubMed ID: 11601754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gene therapy of cystic fibrosis].
    Rochat T
    Schweiz Med Wochenschr; 1999 Nov; 129(46):1779-83. PubMed ID: 10603652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel de novo large deletion in cystic fibrosis transmembrane conductance regulator gene results in a severe cystic fibrosis phenotype.
    Norek A; Stremska M; Sobczyńska-Tomaszewska A; Wertheim-Tysarowska K; Dmeńska H; Jurek M
    J Pediatr; 2011 Aug; 159(2):343-6.e1. PubMed ID: 21663921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator 11234V mutation.
    Al-Mendalawi MD; Abdul-Wahab A; Janahi IA; Abdel-Rahman MO
    Saudi Med J; 2010 Mar; 31(3):339-40; author reply 340. PubMed ID: 20231949
    [No Abstract]   [Full Text] [Related]  

  • 18. Cystic fibrosis: premature degradation of mutant proteins as a molecular disease mechanism.
    Gelman MS; Kopito RR
    Methods Mol Biol; 2003; 232():27-37. PubMed ID: 12840537
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cystic fibrosis lung disease and its management].
    Hidaka N; Hidaka Y
    Nihon Rinsho; 1999 Sep; 57(9):2139-44. PubMed ID: 10497420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic fibrosis.
    Aitken ML
    Curr Opin Pulm Med; 1995 Nov; 1(6):425-34. PubMed ID: 9363078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.